Group One Trading
ITOS

Group One Trading’s iTeos Therapeutics ITOS Stock Holding History

Group One Trading’s Portfolio ITOS Stock Details ITOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-12,327
Closed -$99.3K – 8274
2025
Q1 		$73.6K Sell
12,327
-118,265
-91% -$868K ﹤0.01% 4851
2024
Q4 		$1M Buy
+130,592
New +$1.12M ﹤0.01% 2571
2024
Q3 		– Sell
-23,439
Closed -$358K – 6972
2024
Q2 		$348K Buy
23,439
+16,495
+238% +$236K ﹤0.01% 2900
2024
Q1 		$94.7K Sell
6,944
-78,784
-92% -$858K ﹤0.01% 4202
2023
Q4 		$939K Buy
+85,728
New +$850K ﹤0.01% 2507
2023
Q3 		– Sell
-7,321
Closed -$93.6K – 7954
2023
Q2 		$96.9K Sell
7,321
-6,358
-46% -$90.7K ﹤0.01% 4659
2023
Q1 		$186K Buy
+13,679
New +$245K ﹤0.01% 3743
2022
Q3 		– Sell
-5,500
Closed -$113K – 7852
2022
Q2 		$113K Buy
+5,500
New +$131K ﹤0.01% 4867

Other funds holding ITOS

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Group One Trading's ITOS Position: Q2 2025 in Review

Group One Trading sold out of iTeos Therapeutics (ITOS) in Q2 2025, closing a stake of 12,327 shares — an estimated $99.3K sold.

Group One Trading first reported a position in ITOS in Q2 2022 and held it in 8 quarters. The position peaked at $1M in Q4 2024. 136 funds tracked by Wall St. Rank hold ITOS as of Q2 2025.

  • Group One Trading reported no remaining iTeos Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Group One Trading sold 12,327 iTeos Therapeutics shares in Q2 2025, an estimated $99.3K.
  • Group One Trading first reported a position in iTeos Therapeutics in Q2 2022 and held it in 8 quarters.
  • Group One Trading's iTeos Therapeutics position peaked at $1M in Q4 2024.
  • 136 funds tracked by Wall St. Rank held iTeos Therapeutics as of Q2 2025.

Based on Group One Trading's 13F filing for Q2 2025, filed 14 Aug 2025.